Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Acetate
Therapeutic Area : Nephrology
Study Phase : Approved
Sponsor : Woodward Pharma Services
Deal Size : Not Applicable
Deal Type : Not Applicable
A.forall Announces Launch of a Generic Version of Sodium Acetate Injection 4 mEq/mL
Details : Sodium Acetate-generic Injection is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake.
Brand Name : Sodium Acetate-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 09, 2024
Lead Product(s) : Sodium Acetate
Therapeutic Area : Nephrology
Highest Development Status : Approved
Sponsor : Woodward Pharma Services
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Sodium Acetate
Therapeutic Area : Nephrology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Microscopic and elemental analyses determined the presence of particulates in Maxivial (sodium acetate) injection that is composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.
Brand Name : Maxivial
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 07, 2022
Lead Product(s) : Sodium Acetate
Therapeutic Area : Nephrology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?